Loratadine and Montelukast Administered in Combination Produce Decongestion in an Experimental Feline Model of Nasal Congestion
- 1 November 2009
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 23 (6) , e17-e22
Abstract
Background: Histamine and leukotrienes act to exert numerous local and systemic effects that contribute to the pathophysiology of allergic rhinitis. The aim of these experiments was to evaluate the nasal decongestant effects of loratadine and montelukast alone and in combination in a feline model of nasal congestion. We also studied the decongestant actions of the alpha-agonist adrenergic agonist D-pseudoephedrine with and without desloratadine. Methods: Acoustic rhinometry was used to determine nasal cavity dimensions after intranasal compound 48/80. Cats were given D-pseudoephedrine (0.3 mg/kg) alone or in combination with desloratadine (5 mg/kg) 1 hour before nasal provocation with compound 48/80 (1%, 75 microliters) to either the left or right nasal passageway. Using a similar design, the nasal decongestant effects of montelukast (1 mg/kg) and loratadine (10 mg/kg) were studied alone and in combination. Results: The addition of desloratadine to D-pseudoephedrine did not improve decongestant efficacy compared with each drug given individually. In contrast, when montelukast (1 mg/kg) was given in combination with loratadine (10 mg/kg), the decongestant activity was greater than when these drugs were administered separately. Sixty minutes after compound 48/80 provocation the nasal cavity volume ratio (volume ratio of the compound 48/80 treated/untreated nasal passageway) for the control, montelukast alone, loratadine alone, and the montelukast plus loratadine–treated groups were 0.20 ± 0.03, 0.24 ± 0.01, 0.28 ± 0.03, and 0.50 ± 0.03. Conclusion: Concomitant montelukast plus loratadine produces a greater degree of nasal decongestion compared with montelukast or loratadine alone in an experimental model of nasal congestion.Keywords
This publication has 39 references indexed in Scilit:
- Allergic rhinoconjunctivitis: Burden of diseaseAllergy and Asthma Proceedings, 2007
- Allergic rhinitis and its pharmacologyPharmacology & Therapeutics, 2007
- Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionateAllergy and Asthma Proceedings, 2007
- Influences of Allergic Rhinitis on SleepOtolaryngology–Head and Neck Surgery, 2004
- HistamineJournal of Allergy and Clinical Immunology, 2003
- Direct costs of allergic rhinitis in the united states: Estimates from the 1996 medical expenditure panel surveyJournal of Allergy and Clinical Immunology, 2003
- Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosaJournal of Allergy and Clinical Immunology, 2001
- Allergic RhinitisNew England Journal of Medicine, 1991
- The pathophysiology of rhinitis: V. Sources of protein in allergen-induced nasal secretionsJournal of Allergy and Clinical Immunology, 1991
- Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergyJournal of Allergy and Clinical Immunology, 1990